S. Asenbaum

发表

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

S. Asenbaum, W. Pirker, P. Angelberger, 1998, Journal of neural transmission.

European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals.

A Pupi, A. Pupi, C. Halldin, 2002, European journal of nuclear medicine and molecular imaging.

L. Deecke, W. Lang, S. Asenbaum, 1990, Behavioral and Brain Sciences.

[123I]β-CIT and SPECT in essential tremor and Parkinson's disease

S. Asenbaum, W. Pirker, P. Angelberger, 1998, Journal of Neural Transmission.

European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis

K. Laere, G. Knudsen, A. Varrone, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database

J. Darcourt, K. Laere, A. Varrone, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Topographic distribution of sleep spindles in young healthy subjects

P. Anderer, B. Saletu, G. Gruber, 1997, Journal of sleep research.

Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine

Thomas Czech, Wolfgang Wadsak, Georgios Karanikas, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Application of correlation dimension and pointwise dimension for non-linear topographical analysis of focal onset seizures

H. Witte, F. Benninger, H. Witte, 1999, Medical & Biological Engineering & Computing.

Monitoring of median nerve somatosensory evoked potentials in carotid surgery.

L. Deecke, J. Zeitlhofer, M. Czerny, 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues

K. Van Laere, K. Tatsch, A. Varrone, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Measuring the rate of progression of Parkinson's disease over a 5‐year period with β‐CIT SPECT

G. Zettinig, S. Asenbaum, W. Pirker, 2003, Movement disorders : official journal of the Movement Disorder Society.

SPECT imaging of dopamine receptors with [123I]epidepride: characterization of uptake in the human brain

J. Kornhuber, S. Asenbaum, P. Angelberger, 2005, Journal of Neural Transmission / General Section JNT.

Regional Cerebral Blood Flow During Temporal Lobe Seizures Associated with Ictal Vomiting: An Ictal SPECT Study in Two Patients

U. Pietrzyk, G. Lindinger, E. Pataraia, 1999, Epilepsia.

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality

G Klösch, G. Klösch, J. Zeitlhofer, 2004, Acta neurologica Scandinavica.

Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Psychopharmacology.

[The importance of magnetic field strength in the MR diagnosis of multiple sclerosis: a comparison of 0.5 and 1.5 T].

H. Imhof, D. Wimberger, W. Schima, 1993, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Psychopharmacology.

63-2 Sertindole and dopamine D2 receptor occupancy

S. Kasper, B. Küfferle, S. Asenbaum, 1997, Biological Psychiatry.

P.2.069 123I IBZM spect imaging of dopamine-2 receptors in psychotic patients treated with zotepine

S. Kasper, B. Küfferle, S. Asenbaum, 1997, European Neuropsychopharmacology.

P-4-32 IBZM-SPECT and D2 dopamine receptor occupancy: Different profiles with atypical neuroleptics

S. Kasper, B. Küfferle, S. Asenbaum, 1995, European Neuropsychopharmacology.

Dopamine D2 receptor binding is reduced in Wilson's disease: Correlation of neurological deficits with striatal123I-Iodobenzamide binding

L. Deecke, J. Spatt, H. Kollegger, 2005, Journal of Neural Transmission.

Dopamine D2 receptor SPECT in corticobasal syndrome and autopsy-confirmed corticobasal degeneration.

S. Asenbaum, W. Pirker, G. Kovacs, 2013, Parkinsonism & related disorders.

Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.

L. Deecke, J. Kornhuber, S. Asenbaum, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Impaired olfactory function in Parkinson's disease

I. Kryspin-Exner, J. Lehrner, S. Asenbaum, 1995, The Lancet.

Binding kinetics in the human brain

J. Kornhuber, S. Asenbaum, P. Angelberger, 2022 .

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT

J. Darcourt, K. Laere, G. Knudsen, 2013, EJNMMI Research.

Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.

D. Prayer, J. Hainfellner, S. Asenbaum, 2007, Minimally invasive neurosurgery : MIN.

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics

S. Asenbaum, T. Brücke, I. Podreka, 1992, The Lancet.

224. D2 — Receptor imaging (SPECT) as a tool for measuring the efficacy and side-effect profile of treatment with neuroleptics

S. Kasper, A. Neumeister, S. Asenbaum, 1996, Biological Psychiatry.

123I.-@3-CIT SPECT:Binding Kinetics and Effects of Normal Aging

N. Praschak-Rieder, A. Neumeister, S. Asenbaum, 2000 .

[Postoperative neuropsychiatric disorders and transitory syndromes].

J. Zeitlhofer, S. Asenbaum, L. Deecke, 1992, Der Internist.

Association of central serotonin transporter availability and body mass index in healthy Europeans

J. Darcourt, K. Laere, G. Knudsen, 2014, European Neuropsychopharmacology.

Striatal D2 receptor occupancy in bipolar patients treated with olanzapine

J. Sacher, S. Kasper, N. Mossaheb, 2007, European Neuropsychopharmacology.

Dopamine D2 Receptor Blockade and Antimigraine Action of Flunarizine

S. Asenbaum, T. Brücke, C. Wöber, 1994, Cephalalgia : an international journal of headache.

European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.

A Pupi, A. Pupi, C. Halldin, 2002, European journal of nuclear medicine and molecular imaging.

European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.

A Pupi, A. Pupi, C. Halldin, 2002, European journal of nuclear medicine and molecular imaging.

European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.

A Pupi, A. Pupi, C. Halldin, 2002, European journal of nuclear medicine and molecular imaging.

No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

Kurt Hornik, Alexander Neumeister, Siegfried Kasper, 2001, Biological Psychiatry.

Frontal DC potentials in auditory selective attention.

L. Deecke, W. Lang, G. Lindinger, 1992, Electroencephalography and clinical neurophysiology.

Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls

S. Kasper, N. Praschak-Rieder, A. Neumeister, 2001, Psychological Medicine.

Modern Imaging Methods for the Assessment of Langerhans' Cell Histiocytosis—Associated Neurodegenerative Syndrome: Case Report

D. Prayer, H. Prosch, S. Asenbaum, 2005, Journal of child neurology.

Postictal Psychosis in Temporal Lobe Epilepsy

Ivo Podreka, Christoph Baumgartner, U. Pietrzyk, 2003, Epilepsia.

SPECT/CT Fusion Imaging in Radionuclide Cisternography for Localization of Liquor Leakage Sites

S. Asenbaum, Erhard Suess, M. Hoffmann, 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region

B. Voller, S. Asenbaum, K. Vass, 2001, Neurology.

Familial Hemiplegic Migraine: Follow-up Findings of Diffusion-Weighted Magnetic Resonance Imaging (MRI), Perfusion-MRI and [99mTc] HMPAO-SPECT in a Patient with Prolonged Hemiplegic Aura

S. Asenbaum, C. Wöber, C. Nasel, 2004, Cephalalgia : an international journal of headache.

SPECT and MR imaging in herpes simplex encephalitis.

L. Deecke, G. Goldenberg, D. Wimberger, 1991, Journal of computer assisted tomography.

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study

S. Kasper, A. Neumeister, M. Zwaan, 2001, European Neuropsychopharmacology.

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

J Tauscher, N. Praschak-Rieder, A. Neumeister, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement

D. Prayer, J. Hainfellner, S. Asenbaum, 2010, Cancer.

Brain Tumor Imaging: European Association of Nuclear Medicine Procedure Guidelines

K. Laere, C. Halldin, A. Varrone, 2011 .

Nuclear medicine in the preoperative evaluation of epilepsy

C. Baumgartner, S. Asenbaum, S. ASENBAUM, 2001, Nuclear medicine communications.

[11C] Methionine and [18F] Fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme

C. Marosi, G. Karanikas, S. Asenbaum, 2007, Journal of Neuro-Oncology.

Sequential MRI in a case of Creutzfeldt-Jakob disease

D. Prayer, J. Zeitlhofer, G. Tribl, 2002, Neuroradiology.

D2 Receptor Blockade by Flunarizine and Cinnarizine Explains Extrapyramidal Side Effects. A SPECT Study

L. Deecke, S. Asenbaum, T. Brücke, 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

Alexander Neumeister, Siegfried Kasper, Oliver Vitouch, 2000, Biological Psychiatry.

Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2β-carbomethoxy-3β- (4-iodophenyl)tropane and single photon emission computed tomography

Alexander Neumeister, Siegfried Kasper, Matthäus Willeit, 2000, Biological Psychiatry.

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

S. Kasper, B. Küfferle, S. Asenbaum, 2002, Psychopharmacology.

Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.

L. Deecke, J. Kornhuber, A. Luger, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

Koen Van Laere, Jacques Darcourt, Kjell Någren, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study

Rupert Lanzenberger, Christoph Spindelegger, Siegfried Kasper, 2007, Psychopharmacology.

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram

R. Lanzenberger, J. Sacher, S. Kasper, 2006, Psychopharmacology.

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

Rupert Lanzenberger, Christoph Spindelegger, Siegfried Kasper, 2009, International clinical psychopharmacology.

A medial to lateral shift in pre-movement cortical activity in hemi-Parkinson's disease

G. Dirnberger, W. Lang, R. Cunnington, 2001, Clinical Neurophysiology.

No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers

Marco Pagani, Gitte Moos Knudsen, Koen Van Laere, 2013, NeuroImage.

Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep

J. Zeitlhofer, G. Tribl, R. Bonelli, 2004, Nuclear medicine communications.

[123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

S. Kasper, N. Praschak-Rieder, A. Neumeister, 2001, Biological Psychiatry.

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

J Tauscher, S Kasper, S. Kasper, 2000, Biological psychiatry.

Use of Imaging in Cerebrovascular Disease

M. Brainin, R. Seitz, J. Masdeu, 2010 .

EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force

R. J. Seitz, M. Brainin, J. Bogousslavsky, 2006, European journal of neurology.

Receptor and Transporter Imaging Studies in Schizophrenia, Depression, Bulimia and Tourette's Disorder—Implications for Psychopharmacology-

Ivo Podreka, Alexander Neumeister, Siegfried Kasper, 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Central nervous system function after cardiopulmonary bypass.

E Wolner, J. Zeitlhofer, C. Spiss, 1993, European heart journal.

Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT

I. Podreka, S. Asenbaum, W. Pirker, 1997 .

Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11 C]WAY-100635 PET study

Rupert Lanzenberger, Wolfgang Wadsak, Markus Mitterhauser, 2010, Epilepsy & Behavior.

Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

S. Asenbaum, W. Pirker, T. Brücke, 1997, Journal of neural transmission. Supplementum.

Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.

G. Heinze, J. Sacher, S. Kasper, 2007, The international journal of neuropsychopharmacology.

Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.

G Klösch, G. Klösch, J. Zeitlhofer, 2001, Neurology.

Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding.

L. Deecke, J. Spatt, H. Kollegger, 1996, Journal of neural transmission.

P.3.c.037 Haloperidol in combination with clozapine in treatment-refractory patients with schizophrenia

J. Sacher, S. Kasper, N. Mossaheb, 2006, European Neuropsychopharmacology.

[123I]β‐CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

L. Deecke, D. Prayer, S. Asenbaum, 2000, Movement disorders : official journal of the Movement Disorder Society.

Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls

Claus Svarer, John Dickson, Andrea Varrone, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

S. Kasper, M. Zwaan, S. Asenbaum, 1999, European Neuropsychopharmacology.

β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

I. Podreka, W. Pirker, L. Deecke, 2005, Journal of Neural Transmission / General Section JNT.

Nuclear Medicine in Neurodegenerative Disorders

S. Asenbaum, 2002 .

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

L. Deecke, S. Asenbaum, W. Pirker, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[123I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

B. Bloem, S. Asenbaum, W. Pirker, 2002, Movement disorders : official journal of the Movement Disorder Society.

Diencephalic Serotonin Transporter Availability Predicts Both Transporter Occupancy and Treatment Response to Sertraline in Obsessive-Compulsive Checkers

K. Hornik, K. Thau, M. Aigner, 2009, Biological Psychiatry.

SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT. Binding kinetics in the human brain

J. Kornhuber, S. Asenbaum, P. Angelberger, 2005, Journal of Neural Transmission / General Section JNT.

Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis?

G. Zettinig, M. Mittlboeck, S. Asenbaum, 2003, Clinical endocrinology.

Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls

Jacques Darcourt, Andrea Varrone, Markus Diemling, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Dopamine transporter imaging in autopsy‐confirmed Parkinson's disease and multiple system atrophy

Susanne Pirker, Kurt Jellinger, Martha Hoffmann, 2012, Movement disorders : official journal of the Movement Disorder Society.

Positronenemissionstomographie (PET) in der Neurologie

S. Asenbaum, 2006 .

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β‐CIT SPECT study

Willibald Gerschlager, Martha Hoffmann, G. Tribl, 2002, Movement disorders : official journal of the Movement Disorder Society.

SPECT and PET imaging of the dopaminergic system in Parkinson's disease

S. Asenbaum, W. Pirker, G. Bencsits, 2000, Journal of Neurology.

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β-CIT SPECT study.

Willibald Gerschlager, Martha Hoffmann, G. Tribl, 2002, Movement disorders : official journal of the Movement Disorder Society.

Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes

Jacques Darcourt, Andrea Varrone, Markus Diemling, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement

Thomas Czech, Daniela Prayer, Georg Widhalm, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine

N. Mossaheb, S. Asenbaum, P. Fischer, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Extrapyramidal symptoms with atypical antipsychotics: A [123i]IBZM SPECT study

B. Küfferle, S. Asenbaum, J. Tauscher, 2002, European Neuropsychopharmacology.

Low cerebrovascular reserve capacity in long-term follow-up after subarachnoid hemorrhage.

S. Asenbaum, T. Czech, A. Reinprecht, 2005, Surgical neurology.

Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol – a 123I-IBZM SPECT study

S. Kasper, B. Küfferle, S. Asenbaum, 1998, Psychopharmacology.

Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone

S. Kasper, B. Küfferle, S. Asenbaum, 1996, Psychiatry Research: Neuroimaging.

In vivo 123I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients

S. Kasper, B. Küfferle, M. Willeit, 2001, Psychopharmacology.

In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

P. Fischer, S. Kasper, L. Pezawas, 1999, Psychopharmacology.